BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zandvliet M, Teske E. Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma. Vet Sci 2015;2:150-84. [PMID: 29061939 DOI: 10.3390/vetsci2030150] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Marconato L, Aresu L, Stefanello D, Comazzi S, Martini V, Ferrari R, Riondato F, Rouquet N, Frayssinet P, Sabattini S. Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers. J Immunother Cancer 2019;7:146. [PMID: 31174615 DOI: 10.1186/s40425-019-0624-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
2 Levi M, Muscatello LV, Brunetti B, Benazzi C, Parenti F, Gobbo F, Avallone G, Bacci B, Zambon E, Valenti P, Sarli G. High Intrinsic Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Carcinomas Regardless of Immunophenotype and Outcome. Animals (Basel) 2021;11:658. [PMID: 33801360 DOI: 10.3390/ani11030658] [Reference Citation Analysis]
3 Morita A, Aoshima K, Gulay KCM, Onishi S, Shibata Y, Yasui H, Kobayashi A, Kimura T. High drug efflux pump capacity and low DNA damage response induce doxorubicin resistance in canine hemangiosarcoma cell lines. Res Vet Sci 2019;127:1-10. [PMID: 31648115 DOI: 10.1016/j.rvsc.2019.09.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hlavaty J, Ertl R, Mekuria TA, Rütgen B, Tsujimoto H, Walter I, Wolfesberger B. Effect of prednisolone pre-treatment on cat lymphoma cell sensitivity towards chemotherapeutic drugs. Res Vet Sci 2021;138:178-87. [PMID: 34157499 DOI: 10.1016/j.rvsc.2021.06.014] [Reference Citation Analysis]
5 Manoel VC, De Carvalho PLT, Govoni VM, Da Silva TC, Queiroga FL, Cogliati B. Immunoexpression and Prognostic Significance of Multidrug Resistance Markers in Feline Mammary Carcinomas. J Comp Pathol 2021;183:13-25. [PMID: 33714427 DOI: 10.1016/j.jcpa.2020.12.008] [Reference Citation Analysis]
6 Aberuyi N, Rahgozar S, Pourabutaleb E, Ghaedi K. Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin. Curr Res Transl Med 2021;69:103269. [PMID: 33071214 DOI: 10.1016/j.retram.2020.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Vail DM, Thamm DH, Liptak JM. Hematopoietic Tumors. Withrow and MacEwen's Small Animal Clinical Oncology. Elsevier; 2019. pp. 688-772. [DOI: 10.1016/b978-0-323-59496-7.00033-5] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Chen W, Liu I, Tomiyasu H, Lee J, Cheng C, Liao AT, Liu B, Liu C, Lin C. Imatinib enhances the anti-tumour effect of doxorubicin in canine B-cell lymphoma cell line. Vet J 2019;254:105398. [PMID: 31836165 DOI: 10.1016/j.tvjl.2019.105398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Hsu CH, Tomiyasu H, Liao CH, Lin CS. Genome-wide DNA methylation and RNA-seq analyses identify genes and pathways associated with doxorubicin resistance in a canine diffuse large B-cell lymphoma cell line. PLoS One 2021;16:e0250013. [PMID: 33961622 DOI: 10.1371/journal.pone.0250013] [Reference Citation Analysis]
10 Modiano JF. Comparative Pathogenesis of Cancers in Animals and Humans. Vet Sci 2016;3:E24. [PMID: 29056731 DOI: 10.3390/vetsci3030024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Levi M, Salaroli R, Parenti F, De Maria R, Zannoni A, Bernardini C, Gola C, Brocco A, Marangio A, Benazzi C, Muscatello LV, Brunetti B, Forni M, Sarli G. Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines. BMC Vet Res 2021;17:30. [PMID: 33461558 DOI: 10.1186/s12917-020-02709-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Małek A, Taciak B, Sobczak K, Grzelak A, Wójcik M, Mieczkowski J, Lechowski R, Zabielska-Koczywąs KA. Enhanced Cytotoxic Effect of Doxorubicin Conjugated to Glutathione-Stabilized Gold Nanoparticles in Canine Osteosarcoma-In Vitro Studies. Molecules 2021;26:3487. [PMID: 34201296 DOI: 10.3390/molecules26123487] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Thamm DH, Gustafson DL. Drug dose and drug choice: Optimizing medical therapy for veterinary cancer. Vet Comp Oncol 2020;18:143-51. [PMID: 31487110 DOI: 10.1111/vco.12537] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Wu ZX, Mai Q, Yang Y, Wang JQ, Ma H, Zeng L, Chen ZS, Pan Y. Overexpression of human ATP-binding cassette transporter ABCG2 contributes to reducing the cytotoxicity of GSK1070916 in cancer cells. Biomed Pharmacother 2021;136:111223. [PMID: 33450491 DOI: 10.1016/j.biopha.2021.111223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Levi M, Peña L, Alonso-Díez A, Brunetti B, Muscatello LV, Benazzi C, Pérez-Alenza MD, Sarli G. P-Glycoprotein and Breast Cancer Resistance Protein in Canine Inflammatory and Noninflammatory Grade III Mammary Carcinomas. Vet Pathol 2019;56:840-7. [PMID: 31526115 DOI: 10.1177/0300985819868647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Henklewska M, Pawlak A, Li RF, Yi J, Zbyryt I, Obmińska-Mrukowicz B. Benzyl Isothiocyanate, a Vegetable-Derived Compound, Induces Apoptosis via ROS Accumulation and DNA Damage in Canine Lymphoma and Leukemia Cells. Int J Mol Sci 2021;22:11772. [PMID: 34769202 DOI: 10.3390/ijms222111772] [Reference Citation Analysis]